Table 2.
Perspectives & Methods used to Estimate the Burden of Antimicrobial Resistance
| Patient % (n = 187) | Healthcare System % (n = 75) | Economic % (n = 11) | |
|---|---|---|---|
| Regression Analysis | 44.9% | 34.7% | 9.1% |
| Survival Analysis | 20.9% | 9.3% | 0.0% |
| Matching | 4.8% | 10.7% | 9.1% |
| Multistate model | 2.1% | 6.7% | 27.3% |
| Economic Model | 0.0% | 0.0% | 18.2% |
| Significance Tests | 26.2% | 32.0% | 0.0% |
| Stepwise calculation | 1.1% | 6.7% | 27.3% |
| Qualitative | 0.0% | 0.0% | 9.1% |
Note that some studies included more than one burden perspective per study (for example a study reporting impact on mortality and costs would appear in multiple perspective categories)